Quantitative cardiac phosphoproteomics profiling during ischemia-reperfusion in an immature swine model.
暂无分享,去创建一个
Ljiljana Paša-Tolić | Samuel O. Purvine | L. Paša-Tolić | S. Purvine | H. Brewer | M. Kajimoto | Heather M. Brewer | D. Ledee | Min-Ja Kang | M. Portman | Dolena R. Ledee | MinA Kang | Masaki Kajimoto | Michael A. Portman | M. Kang
[1] D. Yellon,et al. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. , 2013, The Journal of clinical investigation.
[2] Matthew W. Foster,et al. Phosphoproteomic Profiling of Human Myocardial Tissues Distinguishes Ischemic from Non-Ischemic End Stage Heart Failure , 2014, PloS one.
[3] J. Lupski,et al. De novo missense variants in PPP1CB are associated with intellectual disability and congenital heart disease , 2016, Human Genetics.
[4] A. Mattiazzi,et al. Phospholamban phosphorylation by CaMKII under pathophysiological conditions. , 2008, Frontiers in bioscience : a journal and virtual library.
[5] J. Lord,et al. Serine/threonine protein kinases and apoptosis. , 2000, Experimental cell research.
[6] E. Krebs,et al. Protein phosphorylation and signal transduction. , 1999, Pharmacology & therapeutics.
[7] M. Chou,et al. Using the scan‐x Web Site to Predict Protein Post‐Translational Modifications , 2011, Current protocols in bioinformatics.
[8] J. Wrana. TGF-β Receptors and Signalling Mechanisms , 1998, Mineral and Electrolyte Metabolism.
[9] N. Isern,et al. Pyruvate modifies metabolic flux and nutrient sensing during extracorporeal membrane oxygenation in an immature swine model. , 2015, American journal of physiology. Heart and circulatory physiology.
[10] A. Alizadeh,et al. Reactive oxygen species-mediated cardiac-reperfusion injury: Mechanisms and therapies. , 2016, Life sciences.
[11] J. Petrie,et al. AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease , 2009, Clinical science.
[12] E. Ciszak,et al. Phosphorylation of serine 264 impedes active site accessibility in the E1 component of the human pyruvate dehydrogenase multienzyme complex. , 2007, Biochemistry.
[13] P. Lyu,et al. Proteomics study of oxidative stress and Src kinase inhibition in H9C2 cardiomyocytes: a cell model of heart ischemia-reperfusion injury and treatment. , 2010, Free radical biology & medicine.
[14] P. D. del Nido,et al. Exogenous substrate preference of the post-ischaemic myocardium. , 1986, Cardiovascular research.
[15] G. Lopaschuk,et al. Glucose and palmitate oxidation in isolated working rat hearts reperfused after a period of transient global ischemia. , 1990, Circulation research.
[16] J. Mccormack,et al. Pyruvate dehydrogenase activity and malonyl CoA levels in normal and ischemic swine myocardium: effects of dichloroacetate. , 1996, Journal of molecular and cellular cardiology.
[17] N. Isern,et al. Triiodothyronine activates lactate oxidation without impairing fatty acid oxidation and improves weaning from extracorporeal membrane oxygenation. , 2014, Circulation journal : official journal of the Japanese Circulation Society.
[18] R. Xiao,et al. Dual site phospholamban phosphorylation and its physiological relevance in the heart. , 2002, Trends in cardiovascular medicine.
[19] R. Hauer,et al. Cardiac cell-cell junctions in health and disease: Electrical versus mechanical coupling. , 2009, Journal of molecular and cellular cardiology.
[20] J. Ross,et al. Dilated cardiomyopathy caused by tissue‐specific ablation of SC35 in the heart , 2004, The EMBO journal.
[21] George M. Church,et al. Predicting Protein Post-translational Modifications Using Meta-analysis of Proteome Scale Data Sets*S , 2009, Molecular & Cellular Proteomics.
[22] José A. Dianes,et al. 2016 update of the PRIDE database and its related tools , 2016, Nucleic Acids Res..
[23] R. Pearson,et al. Protein kinase phosphorylation site sequences and consensus specificity motifs: tabulations. , 1991, Methods in enzymology.
[24] P. Grinwald. Calcium uptake during post-ischemic reperfusion in the isolated rat heart: influence of extracellular sodium. , 1982, Journal of molecular and cellular cardiology.
[25] Bin Zhang,et al. PhosphoSitePlus, 2014: mutations, PTMs and recalibrations , 2014, Nucleic Acids Res..
[26] Joseph A. Hill,et al. Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy. , 2010, The American journal of cardiology.
[27] Joseph N. Brown,et al. Protein and microRNA biomarkers from lavage, urine, and serum in military personnel evaluated for dyspnea , 2014, BMC Medical Genomics.
[28] W. Hunter,et al. Role of myofilaments and calcium handling in left ventricular relaxation. , 2000, Cardiology clinics.
[29] C. Landry,et al. Weak functional constraints on phosphoproteomes. , 2009, Trends in genetics : TIG.
[30] V. Janssens,et al. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. , 2001, The Biochemical journal.
[31] Guey-Shin Wang,et al. Splicing in disease: disruption of the splicing code and the decoding machinery , 2007, Nature Reviews Genetics.
[32] P. Cohen,et al. Molecular basis for the substrate specificity of protein kinase B; comparison with MAPKAP kinase‐1 and p70 S6 kinase , 1996, FEBS letters.
[33] G. Heusch,et al. The in-situ pig heart with regional ischemia/reperfusion - ready for translation. , 2011, Journal of molecular and cellular cardiology.
[34] Melanie Y. White,et al. The role of post‐translational modifications in acute and chronic cardiovascular disease , 2014, Proteomics. Clinical applications.
[35] E. Schuman,et al. Calcium-dependent dynamics of cadherin interactions at cell–cell junctions , 2011, Proceedings of the National Academy of Sciences.
[36] J. R. Brown,et al. Sites of phosphorylation on pyruvate dehydrogenase from bovine kidney and heart. , 1978, Biochemistry.
[37] P. Hammer,et al. Reduction and redistribution of gap and adherens junction proteins after ischemia and reperfusion. , 2006, The Annals of thoracic surgery.
[38] S. Javadov,et al. Crosstalk between mitogen-activated protein kinases and mitochondria in cardiac diseases: therapeutic perspectives. , 2014, Pharmacology & therapeutics.
[39] Richard D. Smith,et al. Phosphoproteomics Profiling of Human Skin Fibroblast Cells Reveals Pathways and Proteins Affected by Low Doses of Ionizing Radiation , 2010, PloS one.
[40] Eric T. Wang,et al. Alternative Isoform Regulation in Human Tissue Transcriptomes , 2008, Nature.
[41] Qingyu Xiao,et al. Prioritizing functional phosphorylation sites based on multiple feature integration , 2016, Scientific Reports.
[42] Ronald J. Moore,et al. Reversed‐phase chromatography with multiple fraction concatenation strategy for proteome profiling of human MCF10A cells , 2011, Proteomics.
[43] José A. Dianes,et al. 2016 update of the PRIDE database and its related tools , 2015, Nucleic Acids Res..
[44] J. H. Collins,et al. Sequence analysis of phospholamban. Identification of phosphorylation sites and two major structural domains. , 1986, The Journal of biological chemistry.
[45] Rakesh Kumar,et al. Structure, biochemistry, and biology of PAK kinases. , 2017, Gene.
[46] Robert H. Anderson,et al. Anatomy of the pig heart: comparisons with normal human cardiac structure , 1998, Journal of anatomy.
[47] K. Kobayashi,et al. Effects of ischemia and reperfusion on pyruvate dehydrogenase activity in isolated rat hearts. , 1983, Journal of molecular and cellular cardiology.
[48] M. Mocanu,et al. Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. , 2005, American journal of physiology. Heart and circulatory physiology.
[49] G. Angelini,et al. Human Pericardial Fluid Contains Exosomes Enriched with Cardiovascular-Expressed MicroRNAs and Promotes Therapeutic Angiogenesis , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.
[50] P. Mertz,et al. Calcineurin: form and function. , 2000, Physiological reviews.
[51] P. Cohen,et al. Substrate specificity of a multifunctional calmodulin-dependent protein kinase. , 1985, The Journal of biological chemistry.
[52] R. London,et al. Elevation in Cytosolic Free Calcium Concentration Early in Myocardial Ischemia in Perfused Rat Heart , 1987, Circulation research.
[53] Y. Kagawa,et al. Cloning and sequencing of cDNAs encoding alpha and beta subunits of human pyruvate dehydrogenase. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[54] Qiangzhen Yang,et al. Tyrosine phosphorylation of dihydrolipoamide dehydrogenase as a potential cadmium target and its inhibitory role in regulating mouse sperm motility. , 2016, Toxicology.
[55] F. Jordan,et al. Structural alterations induced by ten disease-causing mutations of human dihydrolipoamide dehydrogenase analyzed by hydrogen/deuterium-exchange mass spectrometry: Implications for the structural basis of E3 deficiency. , 2016, Biochimica et biophysica acta.
[56] A. Mattiazzi,et al. Phosphorylation of phospholamban in ischemia-reperfusion injury: Functional role of Thr17 residue , 2004, Molecular and Cellular Biochemistry.
[57] J. Hewitt,et al. Re-evaluation of the Role of Calcium Homeostasis Endoplasmic Reticulum Protein (CHERP) in Cellular Calcium Signaling* , 2012, The Journal of Biological Chemistry.
[58] Richard D. Smith,et al. The influence of sample preparation and replicate analyses on HeLa Cell phosphoproteome coverage. , 2008, Journal of proteome research.
[59] G. Dorn,et al. SR and mitochondria: calcium cross-talk between kissing cousins. , 2013, Journal of molecular and cellular cardiology.
[60] Andrew Emili,et al. Comparative Proteomics Profiling of a Phospholamban Mutant Mouse Model of Dilated Cardiomyopathy Reveals Progressive Intracellular Stress Responses*S , 2008, Molecular & Cellular Proteomics.
[61] Beñat Mallavia,et al. Animal Models of Cardiovascular Diseases , 2011, Journal of biomedicine & biotechnology.
[62] E. Kranias,et al. Role of dual-site phospholamban phosphorylation in the stunned heart: insights from phospholamban site-specific mutants. , 2003, American journal of physiology. Heart and circulatory physiology.
[63] M. Patel,et al. Mutagenesis Studies of the Phosphorylation Sites of Recombinant Human Pyruvate Dehydrogenase. SITE-SPECIFIC REGULATION (*) , 1995, The Journal of Biological Chemistry.
[64] L. Tretter,et al. Stimulation of reactive oxygen species generation by disease-causing mutations of lipoamide dehydrogenase. , 2011, Human molecular genetics.
[65] A. Shah,et al. Contractile Function During Angiotensin-II Activation , 2015, Journal of the American College of Cardiology.
[66] E. Kranias,et al. Transgenic Approaches to Define the Functional Role of Dual Site Phospholamban Phosphorylation* , 1998, The Journal of Biological Chemistry.
[67] G. Angelini,et al. Cardiac Phosphoproteomics during Remote Ischemic Preconditioning: A Role for the Sarcomeric Z-Disk Proteins , 2014, BioMed research international.
[68] K. Mitra,et al. Novel Tyrosine-Phosphorylated Post-Pyruvate Metabolic Enzyme, Dihydrolipoamide Dehydrogenase, Involved in Capacitation of Hamster Spermatozoa1 , 2004, Biology of reproduction.
[69] Hua Yang,et al. Ischemia-induced arrhythmia: the role of connexins, gap junctions, and attendant changes in impulse propagation. , 2005, Journal of electrocardiology.
[70] Pavel A. Pevzner,et al. Universal database search tool for proteomics , 2014, Nature Communications.
[71] Steven P Gygi,et al. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry , 2007, Nature Methods.
[72] S. Yuan. Protein kinase signaling in the modulation of microvascular permeability. , 2002, Vascular pharmacology.
[73] J. Colyer. Phosphorylation States of Phospholambana , 1998 .
[74] A. Sherry,et al. Effects of dichloroacetate on mechanical recovery and oxidation of physiologic substrates after ischemia and reperfusion in the isolated heart. , 1998, Journal of cardiovascular pharmacology.
[75] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[76] K. Parker,et al. Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging Reagents*S , 2004, Molecular & Cellular Proteomics.
[77] T. Patel,et al. Regulation of pyruvate dehydrogenase complex in ischemic rat heart. , 1984, The American journal of physiology.
[78] F. Clubb,et al. Swine as Models in Biomedical Research and Toxicology Testing , 2012, Veterinary pathology.
[79] M. Olson,et al. Rho‐associated kinases in tumorigenesis: re‐considering ROCK inhibition for cancer therapy , 2012, EMBO reports.
[80] Joshua N. Adkins,et al. MASIC: A software program for fast quantitation and flexible visualization of chromatographic profiles from detected LC-MS(/MS) features , 2008, Comput. Biol. Chem..
[81] Jin Han,et al. Echinochrome A regulates phosphorylation of phospholamban Ser16 and Thr17 suppressing cardiac SERCA2A Ca2+ reuptake , 2014, Pflügers Archiv - European Journal of Physiology.
[82] T. Hunter,et al. The Protein Kinase Complement of the Human Genome , 2002, Science.
[83] B. Giepmans,et al. Gap junctional channels are parts of multiprotein complexes. , 2012, Biochimica et biophysica acta.
[84] K. M. Popov,et al. Studies on the regulation of the mitochondrial alpha-ketoacid dehydrogenase complexes and their kinases. , 1997, Advances in enzyme regulation.
[85] Brad T. Sherman,et al. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.
[86] P. Sugden,et al. Amino acid sequences around the sites of phosphorylation in the pig heart pyruvate dehydrogenase complex. , 1979, The Biochemical journal.
[87] K. Poh,et al. Therapeutic synergy and complementarity for ischemia/reperfusion injury: β1-adrenergic blockade and phosphodiesterase-3 inhibition. , 2016, International journal of cardiology.
[88] Ronald J. Moore,et al. Combined pulsed-Q dissociation and electron transfer dissociation for identification and quantification of iTRAQ-labeled phosphopeptides. , 2009, Analytical chemistry.
[89] S. Ikeda,et al. Heart Failure–Associated Changes in RNA Splicing of Sarcomere Genes , 2010, Circulation. Cardiovascular genetics.
[90] N. Isern,et al. Myocardial oxidative metabolism and protein synthesis during mechanical circulatory support by extracorporeal membrane oxygenation. , 2013, American journal of physiology. Heart and circulatory physiology.
[91] N. Isern,et al. Triiodothyronine Facilitates Weaning From Extracorporeal Membrane Oxygenation by Improved Mitochondrial Substrate Utilization , 2014, Journal of the American Heart Association.
[92] S. Sadayappan,et al. Phosphorylation and function of cardiac myosin binding protein-C in health and disease. , 2010, Journal of molecular and cellular cardiology.
[93] David A. Kass,et al. Tackling heart failure in the twenty-first century , 2008, Nature.
[94] Ishtiaq Rehman,et al. iTRAQ underestimation in simple and complex mixtures: "the good, the bad and the ugly". , 2009, Journal of proteome research.
[95] A. Mattiazzi,et al. Phospholamban phosphorylation in ischemia-reperfused heart. Effect of pacing during ischemia and response to a β-adrenergic challenge , 2003, Molecular and Cellular Biochemistry.
[96] Mark D. Huffman,et al. Heart disease and stroke statistics--2013 update: a report from the American Heart Association. , 2013, Circulation.
[97] Richard D. Smith,et al. Large-Scale and Deep Quantitative Proteome Profiling Using Isobaric Labeling Coupled with Two-Dimensional LC-MS/MS. , 2016, Methods in molecular biology.
[98] A. Emili,et al. Using phosphoproteomics to monitor disregulated signaling networks in cardiac disease preceding heart failure. , 2013, Bioanalysis.
[99] Wanqing Sun,et al. Cardiac-Specific Deletion of the Pdha1 Gene Sensitizes Heart to Toxicological Actions of Ischemic Stress. , 2016, Toxicological sciences : an official journal of the Society of Toxicology.
[100] Heiko Horn,et al. In Vivo Phosphoproteomics Analysis Reveals the Cardiac Targets of β-Adrenergic Receptor Signaling , 2013, Science Signaling.
[101] M. Goumans,et al. The microRNA-15 family inhibits the TGFβ-pathway in the heart. , 2014, Cardiovascular research.
[102] A. Panchenko,et al. Phosphorylation in protein-protein binding: effect on stability and function. , 2011, Structure.
[103] Ulrike Mende,et al. Dilated Cardiomyopathy and Heart Failure Caused by a Mutation in Phospholamban , 2003, Science.
[104] K. Gunter,et al. Calcium and mitochondria , 2004, FEBS letters.
[105] T. Hunter,et al. Signaling—2000 and Beyond , 2000, Cell.
[106] R. Poston,et al. Myocardial reperfusion injury: etiology, mechanisms, and therapies. , 2004, The journal of extra-corporeal technology.
[107] L. Becker,et al. Relation between glycolysis and calcium homeostasis in postischemic myocardium. , 1992, Circulation research.
[108] M. Birnbaum,et al. AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. , 2004, The Journal of clinical investigation.
[109] P. Cohen,et al. The regulation of protein function by multisite phosphorylation--a 25 year update. , 2000, Trends in biochemical sciences.
[110] D. Yellon,et al. Myocardial reperfusion injury. , 2007, The New England journal of medicine.
[111] Davide Heller,et al. STRING v10: protein–protein interaction networks, integrated over the tree of life , 2014, Nucleic Acids Res..
[112] R. Hajjar,et al. CaMKII inhibition protects against necrosis and apoptosis in irreversible ischemia-reperfusion injury. , 2007, Cardiovascular research.